US Broker Ratings

Viant Technology Inc. (DSP) Stock Analysis: Exploring a 41.25% Potential Upside in the Ad-Tech Space

Viant Technology Inc. (NASDAQ: DSP) is gaining attention in the investment community as a promising player within the technology sector, specifically in the software – application industry. Headquartered in Irvine,..

ServiceNow, Inc. (NOW) Stock Analysis: Exploring a Potential 68% Upside in the Technology Sector

ServiceNow, Inc. (NYSE: NOW) is capturing the attention of investors with its robust market presence and a significant potential upside of 68.14%. The company, headquartered in Santa Clara, California, operates..

Roper Technologies, Inc. (ROP): An Investor Outlook on its 35% Potential Upside

Roper Technologies, Inc. (NYSE: ROP) presents an intriguing opportunity for investors looking to delve into the technology sector, specifically within the software application industry. With a market cap of $43.56..

DocuSign, Inc. (DOCU) Stock Analysis: Unveiling a 51.90% Potential Upside for Investors

DocuSign, Inc. (NASDAQ: DOCU), a leader in the application software industry, is catching the eye of investors with a notable potential upside of 51.90%. As the company continues to revolutionize..

Manhattan Associates, Inc. (MANH) Stock Analysis: Navigating a 33% Upside Potential

In the competitive landscape of technology stocks, Manhattan Associates, Inc. (NASDAQ: MANH) stands out for its robust growth potential and strategic positioning. With a market cap of $10.04 billion, this..

National Research Corporation (NRC) Stock Analysis: A Healthcare Sector Contender with Impressive ROE and Dividend Yield

National Research Corporation (NASDAQ: NRC) stands as a significant player in the healthcare sector, particularly within the Health Information Services industry. With a market capitalization of $518.47 million, NRC offers..

ServiceTitan, Inc. (TTAN) Stock Analysis: Exploring a 54% Upside Potential Amid Robust Revenue Growth

ServiceTitan, Inc. (TTAN), a key player in the technology sector’s software application industry, continues to capture investor attention with its impressive growth trajectory and substantial market presence. Based in Glendale,..

Kingsoft Cloud Holdings (KC) Stock Analysis: A Look at Its 52.72% Potential Upside

Kingsoft Cloud Holdings Limited (NASDAQ: KC) presents a compelling opportunity for investors willing to explore the technology sector’s dynamic cloud services niche. Headquartered in Beijing, China, Kingsoft Cloud specializes in..

Procore Technologies, Inc. (PCOR) Stock Analysis: Exploring a 39% Potential Upside Amidst Robust Revenue Growth

Procore Technologies, Inc. (PCOR), a leader in the cloud-based construction management software space, continues to carve out its niche in the technology sector. With a market capitalization of $9.79 billion,..

NetClass Technology Inc (NTCL) Stock Analysis: Navigating Challenges in a Volatile Market

NetClass Technology Inc (NTCL), a player in the technology sector focusing on application software, offers an intriguing yet challenging investment opportunity for those interested in the fast-evolving field of online..

Freshworks Inc. (FRSH) Stock Analysis: Exploring a 65% Potential Upside in the Software Sector

Freshworks Inc. (NASDAQ: FRSH), a prominent name in the software-as-a-service (SaaS) industry, has captivated investor interest with a potential upside of 65.72%, based on its current market performance and analyst..

Dayforce, Inc. (DAY) Stock Analysis: Insights on Growth Potential and Analyst Consensus

Dayforce, Inc. (NASDAQ: DAY), a prominent player in the technology sector, operates within the dynamic software application industry, specializing in human capital management (HCM) solutions. With a market capitalization of..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Is a 384.87% Upside Potential Within Reach?

Arcturus Therapeutics Holdings, Inc. (NASDAQ: ARCT) is capturing investor attention with its intriguing blend of high-risk, high-reward potential within the biotechnology sector. With a market capitalization of $206.57 million, this..

Anbio Biotechnology (NNNN) Stock Analysis: A Rollercoaster Year with Growth Potential

Anbio Biotechnology (NNNN), a key player in the healthcare sector specializing in medical instruments and supplies, has experienced a tumultuous ride over the past year. Based in Frankfurt am Main,..

Spok Holdings, Inc. (SPOK) Stock Analysis: High Dividend Yield and 54.87% Upside Potential

Spok Holdings, Inc. (NASDAQ: SPOK) stands out in the healthcare sector, particularly within the health information services industry. Based in the United States, this company has carved out a niche..

CS Disco, Inc. (LAW) Stock Analysis: Unveiling a 32.81% Potential Upside in the Legal Tech Arena

CS Disco, Inc. (NYSE: LAW) has been making waves in the technology sector, specifically within the software application industry, where it provides cutting-edge cloud-native and AI-powered legal products. As an..

Tvardi Therapeutics, Inc. (TVRD) Investor Outlook: Exploring an 84% Potential Upside in Innovative Biotech

Tvardi Therapeutics, Inc. (NASDAQ: TVRD), a pioneering player in the biotechnology sector, is capturing attention with its groundbreaking approach to addressing fibrosis-driven diseases. With a potential upside of 84.40%, individual..

Yalla Group Limited (YALA) Stock Analysis: A 43% Potential Upside in the Booming MENA Tech Sector

Yalla Group Limited (YALA), a notable player in the technology sector, is carving out a promising niche in the Middle East and North Africa (MENA) region’s social networking and gaming..

Kaltura, Inc. (KLTR) Stock Analysis: A Look at Its Potential 133% Upside

Kaltura, Inc. (NASDAQ: KLTR), a prominent player in the software application industry, is drawing significant investor interest due to its substantial potential upside. With a market capitalization of $231.74 million..

Alumis Inc. (ALMS) Stock Analysis: Exploring a 39% Upside in the Biotech Arena

Alumis Inc. (NASDAQ: ALMS) is currently drawing significant attention from investors, with a striking potential upside of nearly 40%. Specializing in the biotechnology sector, this clinical-stage biopharmaceutical company is making..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds